SCHEMBL7465829

SCHEMBL7465829

O=C(O)CC(=O)c1csc(-c2ncc[nH]2)n1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
TLR7 Q9NYK1 2/20 0.36
HPGD P15428 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC8 Q9BY41 2/20 0.35
HDAC6 Q9UBN7 2/20 0.35
TDP1 Q9NUW8 1/20 0.33
SCN9A Q15858 1/20 0.33
ACHE P22303 1/20 0.33
HPGDS O60760 1/20 0.33
TBXAS1 P24557 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27609155 0.84 ALDH1A1 (0.46) ALDH1A1KDM4ETLR7ACHEHPGDS
SCHEMBL7460091 0.81 HPGDS (0.38) ALDH1A1KDM4ETLR7HPGDHDAC1
SCHEMBL3062139 0.80 HTR2B (0.48) ALDH1A1KDM4ETLR7HPGDCYP2C9
SCHEMBL3065517 0.76 MAPT (0.54) ALDH1A1CYP1A2CYP2C19TDP1ACHE
SCHEMBL5201609 0.76 HPGDS (0.42) ALDH1A1KDM4ETLR7HPGDCYP1A2
SCHEMBL31216572 0.72 HTR3E (0.37) TLR7HPGDCYP1A2CYP3A4CYP2C9
SCHEMBL31216569 0.70 TYR (0.39) KDM4ETLR7HPGDHDAC1HDAC8
SCHEMBL27905839 0.69 SCN9A (0.48) ALDH1A1KDM4EHPGDCYP3A4TDP1
SCHEMBL31216451 0.68 PIM1 (0.36) TLR7HPGDHDAC1HDAC8HDAC6
SCHEMBL25426474 0.67 TLR7 (0.39) ALDH1A1KDM4ETLR7HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224175-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
WO-2001029012-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed